OneAscent Wealth Management LLC Has $761,000 Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

OneAscent Wealth Management LLC decreased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 17.2% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,906 shares of the medical equipment provider’s stock after selling 397 shares during the period. OneAscent Wealth Management LLC’s holdings in Intuitive Surgical were worth $761,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of the company. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA boosted its stake in Intuitive Surgical by 0.3% during the 4th quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA now owns 8,899 shares of the medical equipment provider’s stock valued at $3,002,000 after purchasing an additional 27 shares during the period. Advance Capital Management Inc. increased its stake in shares of Intuitive Surgical by 3.8% in the first quarter. Advance Capital Management Inc. now owns 740 shares of the medical equipment provider’s stock valued at $295,000 after buying an additional 27 shares in the last quarter. Sheaff Brock Investment Advisors LLC lifted its position in Intuitive Surgical by 1.3% during the 4th quarter. Sheaff Brock Investment Advisors LLC now owns 2,226 shares of the medical equipment provider’s stock valued at $751,000 after purchasing an additional 29 shares during the period. Liberty Capital Management Inc. boosted its stake in Intuitive Surgical by 3.8% in the fourth quarter. Liberty Capital Management Inc. now owns 815 shares of the medical equipment provider’s stock valued at $275,000 after acquiring an additional 30 shares during the last quarter. Finally, NBC Securities Inc. lifted its stake in Intuitive Surgical by 34.4% in the first quarter. NBC Securities Inc. now owns 121 shares of the medical equipment provider’s stock valued at $48,000 after buying an additional 31 shares during the period. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on the company. Jefferies Financial Group lifted their price target on Intuitive Surgical from $365.00 to $375.00 and gave the company a “hold” rating in a research note on Friday, April 19th. Citigroup boosted their target price on Intuitive Surgical from $428.00 to $462.00 and gave the stock a “buy” rating in a research note on Wednesday, April 3rd. Robert W. Baird cut their target price on shares of Intuitive Surgical from $440.00 to $436.00 and set an “outperform” rating on the stock in a research report on Friday, April 19th. Piper Sandler lifted their target price on Intuitive Surgical from $425.00 to $435.00 and gave the stock an “overweight” rating in a report on Friday, April 19th. Finally, BTIG Research boosted their price target on shares of Intuitive Surgical from $412.00 to $421.00 and gave the stock a “buy” rating in a research report on Friday, April 19th. Five equities research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. According to MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus target price of $403.67.

Insider Activity at Intuitive Surgical

In other news, SVP Mark Brosius sold 175 shares of the company’s stock in a transaction on Monday, May 13th. The stock was sold at an average price of $389.16, for a total transaction of $68,103.00. Following the transaction, the senior vice president now directly owns 883 shares of the company’s stock, valued at $343,628.28. The sale was disclosed in a filing with the SEC, which is available at the SEC website. In related news, SVP Mark Brosius sold 175 shares of the firm’s stock in a transaction that occurred on Monday, May 13th. The shares were sold at an average price of $389.16, for a total value of $68,103.00. Following the sale, the senior vice president now owns 883 shares in the company, valued at $343,628.28. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Myriam Curet sold 5,318 shares of the stock in a transaction on Tuesday, April 23rd. The shares were sold at an average price of $370.66, for a total value of $1,971,169.88. Following the transaction, the executive vice president now directly owns 298 shares in the company, valued at $110,456.68. The disclosure for this sale can be found here. In the last three months, insiders have sold 17,956 shares of company stock valued at $6,927,011. 0.90% of the stock is owned by corporate insiders.

Intuitive Surgical Stock Down 0.1 %

Shares of ISRG traded down $0.26 during trading hours on Friday, reaching $444.85. 3,106,192 shares of the company traded hands, compared to its average volume of 1,372,778. The company’s fifty day moving average price is $403.83 and its two-hundred day moving average price is $382.69. The company has a market capitalization of $157.79 billion, a price-to-earnings ratio of 80.30, a price-to-earnings-growth ratio of 5.75 and a beta of 1.39. Intuitive Surgical, Inc. has a 12 month low of $254.85 and a 12 month high of $447.11.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.40 by $0.10. The firm had revenue of $1.89 billion during the quarter, compared to analyst estimates of $1.87 billion. Intuitive Surgical had a net margin of 27.16% and a return on equity of 12.91%. The business’s revenue was up 11.5% on a year-over-year basis. During the same period last year, the business earned $1.00 earnings per share. On average, analysts expect that Intuitive Surgical, Inc. will post 4.8 EPS for the current year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.